Atlas Trials

HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant

Clinical trial NCT02902120 · COMPLETED

Trial details

NCT number
NCT02902120
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis CRenal Insufficiency, ChronicDisorder of Transplanted Kidney
Start date
2017-05-01
Primary completion
2021-09-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.